GlassScriptPhysician profile
Matthew S Tobin
NPI 1366425332
$2,094.60
in general payments reported to CMS, 2019-2025
38 companies · $400 in 2025
The $400 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $414 · 2020: $163 · 2021: $285 · 2022: $487 · 2023: $193 · 2024: $152 · 2025: $400.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $746.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $745.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Antares Pharma, INC. | $390.61 | 2019-2025 | Xyosted, Nocdurna, Tlando |
| Calyxo, INC. | $204.01 | 2025 | Cvac Aspiration System |
| Myovant Sciences INC. | $124.78 | 2021-2022 | |
| Medtronic USA, INC. | $119.52 | 2019-2020 | |
| Astellas Pharma US INC | $114.80 | 2019-2021 | |
| Coloplast Corp | $98.75 | 2019-2024 | Porges Coloplast, Speedicath |
| Medtronic, INC. | $92.10 | 2022 | |
| Dentsply Ih Ab | $75.43 | 2024-2025 | Lofric |
| Axonics, INC. | $71.00 | 2022-2024 | Axonics |
| Boston Scientific Corporation | $58.79 | 2023-2025 | Spaceoar Vue System - 10ml |
| Abbvie INC. | $57.20 | 2020-2024 | |
| Janssen Biotech, INC. | $56.98 | 2019-2022 | |
| Teleflex LLC | $55.78 | 2021-2024 | Urolift, Solesta |
| Olympus America INC. | $51.82 | 2023-2025 | Itind System, Cysto-Nephro Videoscope |
| Urogen Pharma, INC. | $45.00 | 2022-2024 | Jelmyto |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Tobin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.